EFPIA - NEWSLETTER

EFPIA Newsletter 26 July 2018

PARADIGM Survey to Find Out Stakeholders’ Needs and Expectations for Patient Engagement in the Medicines Research and Development Lifecycle

Last days to take part in the PARADIGM survey to improve patient engagement.

PARADIGM is working with all relevant stakeholders to improve the way patients are involved in the medicines lifecycle, particularly in three specific phases:
- Research and priority setting
- Design of clinical trials
- Early dialogue with regulators and HTA bodies

You can access the survey here.

Join the EFPIA team

Videos

A lifetime of breakthroughs

We were born to end patients’ suffering. To extend life and improve its quality. And right now, after decades of tireless medical innovation, we still won’t rest.

More good days for people living with migraines, for a brighter tomorrow

New CGRP inhibitors are helping mediate migraine attacks.

Events

27 SEP 2018

28052018 ITCC-P4 International Workshop: Improving pediatric oncology drug development... Amsterdam, The Netherlands

The overarching goal is to streamline and improve the development of new oncology drugs for children and adolescents...

Learn more →

20 NOV 2018

War On Cancer Europe 2018 London

The technological revolution and the future of patient engagement - A conference organised by The Economist

Learn more →

What we are reading

IMI Newsletter 25 July 2018 (IMI)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶